Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial.
Hartmann JA, Schmidt SJ, McGorry PD, Berger M, Berger GE, Chen EYH, de Haan L, Hickie IB, Lavoie S, Markulev C, Mossaheb N, Nieman DH, Nordentoft M, Polari A, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Thompson A, Verma SK, Yuen HP, Yung AR, Amminger GP, Nelson B.
Hartmann JA, et al. Among authors: smesny s.
Behav Res Ther. 2020 Jan;124:103527. doi: 10.1016/j.brat.2019.103527. Epub 2019 Nov 21.
Behav Res Ther. 2020.
PMID: 31790853